Speaker illustration

Doctor Yu He

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)

Event: ESC Congress 2024

Topic: Cardiovascular Pharmacotherapy

Session: Biotherapies in cardiovascular disease: from bench to bedside

Thumbnail